143 related articles for article (PubMed ID: 30628163)
1. Sarcosine is a prostate epigenetic modifier that elicits aberrant methylation patterns through the SAMe-Dnmts axis.
Strmiska V; Michalek P; Lackova Z; Guran R; Krizkova S; Vanickova L; Zitka O; Stiborova M; Eckschlager T; Klejdus B; Pacik D; Tvrdikova E; Keil C; Haase H; Adam V; Heger Z
Mol Oncol; 2019 May; 13(5):1002-1017. PubMed ID: 30628163
[TBL] [Abstract][Full Text] [Related]
2. Epigenetics Reactivation of Nrf2 in Prostate TRAMP C1 Cells by Curcumin Analogue FN1.
Li W; Pung D; Su ZY; Guo Y; Zhang C; Yang AY; Zheng X; Du ZY; Zhang K; Kong AN
Chem Res Toxicol; 2016 Apr; 29(4):694-703. PubMed ID: 26991801
[TBL] [Abstract][Full Text] [Related]
3. Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue.
Geybels MS; Zhao S; Wong CJ; Bibikova M; Klotzle B; Wu M; Ostrander EA; Fan JB; Feng Z; Stanford JL
Prostate; 2015 Dec; 75(16):1941-50. PubMed ID: 26383847
[TBL] [Abstract][Full Text] [Related]
4. Sarcosine influences apoptosis and growth of prostate cells via cell-type specific regulation of distinct sets of genes.
Rodrigo MAM; Strmiska V; Horackova E; Buchtelova H; Michalek P; Stiborova M; Eckschlager T; Adam V; Heger Z
Prostate; 2018 Feb; 78(2):104-112. PubMed ID: 29105933
[TBL] [Abstract][Full Text] [Related]
5. DNA Methylation-Mediated Downregulation of DEFB1 in Prostate Cancer Cells.
Lee J; Han JH; Jang A; Kim JW; Hong SA; Myung SC
PLoS One; 2016; 11(11):e0166664. PubMed ID: 27835705
[TBL] [Abstract][Full Text] [Related]
6. Relation of exposure to amino acids involved in sarcosine metabolic pathway on behavior of non-tumor and malignant prostatic cell lines.
Heger Z; Gumulec J; Cernei N; Polanska H; Raudenska M; Masarik M; Eckschlager T; Stiborova M; Adam V; Kizek R
Prostate; 2016 May; 76(7):679-90. PubMed ID: 26847870
[TBL] [Abstract][Full Text] [Related]
7. The Epigenetic Modifier 5-Aza-2-deoxycytidine Triggers the Expression of
Dudzik P; Trojan SE; Ostrowska B; Zemanek G; Dulińska-Litewka J; Laidler P; Kocemba-Pilarczyk KA
Anticancer Res; 2019 May; 39(5):2395-2403. PubMed ID: 31092432
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic reactivation of RASSF1A by phenethyl isothiocyanate (PEITC) and promotion of apoptosis in LNCaP cells.
Boyanapalli SS; Li W; Fuentes F; Guo Y; Ramirez CN; Gonzalez XP; Pung D; Kong AN
Pharmacol Res; 2016 Dec; 114():175-184. PubMed ID: 27818231
[TBL] [Abstract][Full Text] [Related]
10. Sarcosine Up-Regulates Expression of Genes Involved in Cell Cycle Progression of Metastatic Models of Prostate Cancer.
Heger Z; Merlos Rodrigo MA; Michalek P; Polanska H; Masarik M; Vit V; Plevova M; Pacik D; Eckschlager T; Stiborova M; Adam V
PLoS One; 2016; 11(11):e0165830. PubMed ID: 27824899
[TBL] [Abstract][Full Text] [Related]
11. Disulfiram and its novel derivative sensitize prostate cancer cells to the growth regulatory mechanisms of the cell by re-expressing the epigenetically repressed tumor suppressor-estrogen receptor β.
Sharma V; Verma V; Lal N; Yadav SK; Sarkar S; Mandalapu D; Porwal K; Rawat T; Maikhuri JP; Rajender S; Sharma VL; Gupta G
Mol Carcinog; 2016 Nov; 55(11):1843-1857. PubMed ID: 26599461
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide profiling of DNA methylation reveals preferred sequences of DNMTs in hepatocellular carcinoma cells.
Fan H; Zhao Z; Cheng Y; Cui H; Qiao F; Wang L; Hu J; Wu H; Song W
Tumour Biol; 2016 Jan; 37(1):877-85. PubMed ID: 26254611
[TBL] [Abstract][Full Text] [Related]
13. The triterpenoid corosolic acid blocks transformation and epigenetically reactivates Nrf2 in TRAMP-C1 prostate cells.
Yang J; Wu R; Li W; Gao L; Yang Y; Li P; Kong AN
Mol Carcinog; 2018 Apr; 57(4):512-521. PubMed ID: 29247555
[TBL] [Abstract][Full Text] [Related]
14. DNA hypermethylation associated with upregulated gene expression in prostate cancer demonstrates the diversity of epigenetic regulation.
Rauluseviciute I; Drabløs F; Rye MB
BMC Med Genomics; 2020 Jan; 13(1):6. PubMed ID: 31914996
[TBL] [Abstract][Full Text] [Related]
15. Promoter CpG-Site Methylation of the KAI1 Metastasis Suppressor Gene Contributes to Its Epigenetic Repression in Prostate Cancer.
Lee J; Lee MS; Jeoung DI; Kim YM; Lee H
Prostate; 2017 Mar; 77(4):350-360. PubMed ID: 27813113
[TBL] [Abstract][Full Text] [Related]
16. Aberrant epigenetic modifications in the CTCF binding domain of the IGF2/H19 gene in prostate cancer compared with benign prostate hyperplasia.
Paradowska A; Fenic I; Konrad L; Sturm K; Wagenlehner F; Weidner W; Steger K
Int J Oncol; 2009 Jul; 35(1):87-96. PubMed ID: 19513555
[TBL] [Abstract][Full Text] [Related]
17. Genistein Induces Alterations of Epigenetic Modulatory Signatures in Human Cervical Cancer Cells.
Sundaram MK; Ansari MZ; Al Mutery A; Ashraf M; Nasab R; Rai S; Rais N; Hussain A
Anticancer Agents Med Chem; 2018; 18(3):412-421. PubMed ID: 28925878
[TBL] [Abstract][Full Text] [Related]
18. The role of sarcosine metabolism in prostate cancer progression.
Khan AP; Rajendiran TM; Ateeq B; Asangani IA; Athanikar JN; Yocum AK; Mehra R; Siddiqui J; Palapattu G; Wei JT; Michailidis G; Sreekumar A; Chinnaiyan AM
Neoplasia; 2013 May; 15(5):491-501. PubMed ID: 23633921
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic CpG Methylation of the Promoter and Reactivation of the Expression of GSTP1 by Astaxanthin in Human Prostate LNCaP Cells.
Yang Y; Fuentes F; Shu L; Wang C; Pung D; Li W; Zhang C; Guo Y; Kong AN
AAPS J; 2017 Mar; 19(2):421-430. PubMed ID: 27913949
[TBL] [Abstract][Full Text] [Related]
20. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
Pulukuri SM; Rao JS
Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]